Lipid Guidelines and Global Cardiovascular Prevention

In this episode of the Global Heart Podcast, we explore the latest developments in lipid management and cardiovascular prevention through a discussion of two influential publications: the 2026 ACC/AHA Guideline on the Management of Dyslipidemia and the recent Global Heart paper, Global Lipid Guidance: More Aligned Than They Appear. Together, they provide new insights into how evidence-based lipid management can reduce the global burden of cardiovascular disease. 

Prof. Roger Blumenthal outlines the major updates in the 2026 ACC/AHA dyslipidemia guideline, including earlier lipid screening, lifetime cardiovascular risk assessment, LDL cholesterol goals, lipoprotein(a) testing, coronary artery calcium scoring and personalised treatment strategies. He explains why identifying and treating elevated cholesterol earlier can prevent heart attacks and strokes later in life. 

Prof. Maciej Banach discusses the growing international consensus on cholesterol management, highlighting how global lipid guidelines are becoming increasingly aligned. He explores the importance of lowering LDL cholesterol early and for longer, combination lipid-lowering therapy, residual cardiovascular risk, and the implementation challenges that continue to limit effective prevention around the world. 

Together, they discuss:

• Why dyslipidemia remains one of the most overlooked cardiovascular risk factors
• The key updates in the 2026 ACC/AHA Guideline on the Management of Dyslipidemia
• How international lipid guidelines are becoming increasingly aligned
• Why early detection and treatment of elevated LDL cholesterol matter
• The role of lifetime cardiovascular risk assessment and personalised prevention
• Lipoprotein(a), apolipoprotein B and non-HDL cholesterol in clinical practice
• The growing evidence for combination lipid-lowering therapy
• Barriers to implementing cholesterol guidelines across different healthcare systems
• The importance of lifestyle, education and cardiovascular risk awareness
• How collaboration and implementation can strengthen global cardiovascular prevention

This episode is particularly relevant for cardiologists, primary care physicians, researchers, policymakers, public health professionals and healthcare leaders working to improve cholesterol management, strengthen cardiovascular prevention, and reduce the global impact of cardiovascular disease. 

Further reading and resources:

2026 ACC/AHA Guideline on the Management of Dyslipidemia
https://www.jacc.org/doi/10.1016/j.jacc.2025.12.014

Global Lipid Guidance: More Aligned Than They Appear (Global Heart)
https://globalheartjournal.com/articles/10.5334/gh.1559

World Heart Federation – Cholesterol Resources
https://world-heart-federation.org/heart-health/cholesterol/